doi: 10.1007/s12020-016-1088-1 194 ColaoAGalderisiMDi SarnoAPardoMGaccioneMDAndreaMet al
More GLP-1 drugs are coming, and some are more effective and convenient, which could bring more competition and potentially lower unit cost
it works on growth hormone pathways, stimulates IGF-1, which triggers the production of muscle protein
Instead, the draw is the promise of staying healthy enough to keep training consistently, even through setbacks
Receding Gums : As the disease progresses, gums recede, exposing more of the tooth and its root
Of those 161 patients, 16 (10%) experienced recurrent acute pancreatitis after GLP-1 receptor agonist therapy (mean duration 10.8 7.2 months): 6 (38%) were caused by the GLP-1 receptor agonist (as clinically determined by the treating medical team), three (18%) were due to hypertriglyceridemia, two (12%) due to alcohol use, one (6%) due to another oral hypoglycemic agent, one (6%) due to ampulla stenosis, and three (19%) were idiopathic
